Alzheimer's disease

Alzheimer’s disease market expected to reach $13.7bn across the 8MM by 2030
Clinical Trials Arena
Wed, 05/31/23 - 10:53 am
Alzheimer's disease
Amyloid-Beta Structure Revelation Sheds Light on Leqembi’s Function
BioSpace
Wed, 05/24/23 - 06:51 pm
Eisai
Biogen
Alzheimer's disease
Leqembi
amyloid beta
JAMA: Leqembi could cost Medicare up to $5B per year
Medical Marketing and Media
Mon, 05/15/23 - 06:20 pm
Biogen
Eisai
Leqembi
drug pricing
Medicare
Alzheimer's disease
JAMA
Alzheimer’s doctors see promise, limits in Lilly’s latest drug data
BioPharma Dive
Thu, 05/11/23 - 11:14 am
Eli Lilly
donanemab
Alzheimer's disease
physicians
Lilly's Donanemab Data Energizes Alzheimer’s Sector, Safety Concerns Remain
BioSpace
Thu, 05/4/23 - 10:27 am
Eli Lilly
Alzheimer's disease
donanemab
For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest
Stat
Wed, 05/3/23 - 10:39 pm
Eli Lilly
Alzheimer's disease
Daniel Skovronsky
Lilly drug slows Alzheimer’s decline in large study
BioPharma Dive
Wed, 05/3/23 - 11:54 am
Eli Lilly
donanemab
clinical trials
Alzheimer's disease
Alnylam’s early Alzheimer’s results encourage, but company discloses new hurdle
BioPharma Dive
Fri, 04/28/23 - 10:08 am
Alnylam
Regeneron
clinical trials
Alzheimer's disease
ALN-APP
Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
CNBC
Wed, 04/26/23 - 09:59 am
Biogen
earnings
Pharma CEOs
Chris Viehbacher
Eli Lilly
Alzheimer's disease
Leqembi
donanemab
Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs
Reuters
Fri, 04/21/23 - 10:24 am
Eli Lilly
Medicare
Alzheimer's disease
Leqembi
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation
Fierce Pharma
Sun, 04/16/23 - 11:17 pm
Lundbeck
Otsuka
Rexulti
Alzheimer's disease
FDA
Biogen buys into Denali’s amyloid beta program
Pharmaphorum
Thu, 04/13/23 - 10:05 am
Biogen
Denali Therapeutics
Alzheimer's disease
Lilly says experimental Alzheimer's drug reduces amyloid in small study
Reuters
Mon, 04/3/23 - 09:54 am
Eli Lilly
Alzheimer's disease
clinical trials
remternetug
Coya Therapeutics reports data from Alzheimer’s Disease therapy trial
Clinical Trials Arena
Mon, 04/3/23 - 09:42 am
Coya Therapeutics
COYA 301
clinical trials
Alzheimer's disease
Biogen Successfully Targets Tau in Phase Ib Alzheimer's Study
BioSpace
Thu, 03/30/23 - 11:02 pm
Biogen
Alzheimer's disease
clinical trials
Otsuka, Lundbeck eye Alzheimer's indication in FDA adcomm for Rexulti label expansion
Endpoints
Thu, 03/30/23 - 10:02 am
Otsuka
Lundbeck
Alzheimer's disease
FDA
Rexulti
Alzheimer's disease agitation
Help wanted: Vaxxinity seeks a partner to press ahead with Alzheimer's treatment
Fierce Biotech
Tue, 03/28/23 - 10:11 am
Vaxxinity
Alzheimer's disease
clinical trials
UB-311
Neurotechnology company Cognito Therapeutics scores $73M to study Alzheimer's device
Mobihealthnews
Thu, 03/23/23 - 09:19 pm
Cognito Therapeutics
Alzheimer's disease
Medtech
funding
neuromodulation
Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
PM Live
Wed, 03/22/23 - 10:15 am
Roche
Eli Lilly
Alzheimer's disease
diagnostics
Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO
Fierce Pharma
Tue, 03/21/23 - 09:58 pm
Eisai
Leqembi
FDA
CMS
Alzheimer's disease

Pages